Self-infusion sounds innocuous enough until you consider the reality: using a hypodermic syringe to inject clotting factor concentrates directly into...

Researchers plan to use these tests to work with blood banks to help protect the blood supply.

An array of new medications to treat HCV hit the market.

Update, February 9, 2016: The FDA has approved the expanded use of Daklinza® to include patients with hepatitis C virus...

Sound waves, such as ultrasound, are used in everything from home motion-detector sensors to evaluating fetal development during pregnancy. They’re...

Update, February 9, 2016: The FDA has approved the expanded use of Daklinza®to include patients with hepatitis C virus (HCV)...

As baby boomers age, they’ll not only face arthritis, but the possibility of another “itis” with even greater consequence—hepatitis. In...

Update, October 22, 2015: The US Food and Drug Administration (FDA) issued a warning that AbbVie’s Viekira Pak® and Technivie™...

The release of two new oral medications, IncivekTM and ­VictrelisTM, in May 2011 marks another significant advance in the fight...

Update, October 10, 2014: On October 10, 2014, the US Food and Drug Administration (FDA) approved Harvoni™, a combination of...

In May 2011, the FDA approved boceprevir (trade name Victrelis) and telaprevir (trade name Incivek), both protease inhibitors. Learn more...

For years, patients with hepatitis C have complained of loss of concentration, memory lapses and shortened attention span. It turns...